Ocular Therapeutix: Why SOL-1 Trial Outcome Is Likely Positive

Ocular Therapeutix (OCUL) is a Strong Buy, driven by the pivotal SOL-1 Phase 3 trial for AXPAXLI™ in wet AMD, with topline ...
Wellbeing Whisper on MSN

Wearing a bulky hoodie to the airport can quietly add minutes at security

Its user can get everything perfect boarding pass in hand, liquids in their correct baggie, pockets empty, and find ...